Milbemycin Oxime
5-didehydromilbemycin derivatives (A4 and A3)
Also known as: Interceptor Β· Sentinel Β· Milbemite Β· CGA-179246
Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Dosing by species
π NA β North Americaπ EU β Europe
Dogs
| Indication | Dose | Route | Frequency | Duration | Region |
|---|---|---|---|---|---|
| Heartworm prophylaxis, control of adult hookworms, roundworms, and whipworms | 0.5 mg/kg PO once a month | PO | q30d | β | π NA |
| Microfilaricide chemotherapy (in adulticide-pretreated dogs) | 0.5 mg/kg PO | PO | once | β | π NA |
| Treatment of generalized demodicosis | 1-3 mg/kg/day PO | PO | q24h | Until resolved | π NA |
| Treatment of cheyletiellosis | 2 mg/kg PO every 7 days for 3 doses | PO | q7d | 3 doses | π NA |
| Treatment of scabies | 2 mg/kg PO every 7 days for 3 doses or 0.75 mg/kg once daily for 30 days | PO | q7d or q24h | 3 doses or 30 days | π NA |
| Chronic rhinitis caused by Pneumonyssus caninum | 1 mg/kg PO once every 10 days for 3 treatments | PO | q10d | 3 treatments | π NA |
- Heartworm prophylaxis, control of adult hookworms, roundworms, and whipworms: Minimum dosage. Can also be used with nitenpyram for flea control.
- Microfilaricide chemotherapy (in adulticide-pretreated dogs): Repeat in 2 weeks if necessary. Give approximately one month after melarsomine.
- Treatment of generalized demodicosis: Begin at 1 mg/kg/day with skin scraping after 30 days. Increase to 2 mg/kg if minimal improvement, then 3 mg/kg if needed. Dogs homozygous for MDR1 mutation can show neuro side effects at 1-2.2 mg/kg/day.
Cats
| Indication | Dose | Route | Frequency | Duration | Region |
|---|---|---|---|---|---|
| Prevention of heartworm; treat adult hookworm and adult roundworms | 2 mg/kg PO once monthly | PO | q30d | β | π NA |
Reptiles
| Indication | Dose | Route | Frequency | Duration | Region |
|---|---|---|---|---|---|
| Nematodes | 0.5-1 mg/kg PO; repeat in 2 weeks | PO | once, repeat in 14 days | Until clear | π NA |
- Nematodes: If 14 days after second dose fecal is positive, a third dose is given. Appears to be safe in chelonians (unlike ivermectin).
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Overview
Milbemycin oxime is a macrolide anthelmintic (macrocyclic lactone) widely used in veterinary medicine.
- Primary use: Monthly heartworm (Dirofilaria immitis) prophylaxis and intestinal parasite control (hookworms, roundworms, whipworms).
- Off-label uses: Treatment of generalized demodicosis, scabies, cheyletiellosis, and nasal mites.
Clinical Pearl: While generally safe, caution is required when using high, daily doses for demodicosis in breeds with the ABCB1 (MDR1) mutation (e.g., Collies, Australian Shepherds, Shelties), as they are more susceptible to neurologic toxicity. It is often considered a safer alternative to ivermectin for these breeds, but genetic testing is still recommended before initiating high-dose therapy.
Mechanism of action
Milbemycin acts primarily on the nervous system of invertebrates.
- Binds to glutamate-gated chloride channels and GABA receptors in the parasite's nervous system.
- This binding increases membrane permeability to chloride ions β hyperpolarization of nerve and muscle cells.
- Results in flaccid paralysis and death of the parasite.
Note: Mammals are generally protected because their GABA receptors are confined to the central nervous system, and intact P-glycoprotein (P-gp) pumps at the blood-brain barrier prevent the drug from accumulating in the CNS.
Safety & warnings
Contraindications
- Puppies less than 4 weeks of age or less than 2 lbs
- Kittens less than 6 weeks of age or less than 1.5 lbs
Adverse effects
- Transient shock-like syndrome (in microfilaremic animals)
- Ataxia
- Trembling
- Mydriasis
- Hypersalivation
- Lethargy
- Pyrexia
- Seizures
- Coma
Precautions
Because some dogs with a high number of circulating microfilaria will develop a transient, shock-like syndrome after receiving milbemycin, testing for preexisting heartworm infections is recommended before use. If using at doses greater than labeled in breeds susceptible to the ABCB1 genetic mutation, genetic testing is recommended before initiating therapy. Safety in breeding, pregnant, and lactating queens and breeding toms has not been established.
Drug interactions
Effects may be potentiated by milbemycin; concurrent use is not advised in humans and warrants caution in animals.
May inhibit the efflux pump at the blood-brain barrier, increasing the risk of milbemycin neurotoxicity, particularly in dogs at risk for the ABCB1-1 (MDR1) mutation.
Monitoring
- Heartworm status (prior to initiation of therapy)
- Neurologic signs (especially in susceptible breeds or at high doses)
- Skin scrapings (if treating demodicosis)
Overdose
Beagles have tolerated a single oral dose of 200 mg/kg (200 times monthly rate). Rough-coated collies have tolerated doses of 10 mg/kg (20 times labeled) without adversity. Toxic doses can cause mydriasis, hypersalivation, lethargy, ataxia, pyrexia, seizures, coma, and death. There is no specific antidotal treatment; supportive therapy is recommended.
Available products
Formulations
- Oral tablets
- Otic solution
Veterinary
- Interceptor Flavor Tabs: 2.3 mg, 5.75 mg, 11.5 mg, 23 mg
- Sentinel Flavor Tabs (milbemycin/lufenuron): 46 mg/115 mg/230 mg/460 mg milbemycin/lufenuron combinations
- Milbemite 0.1% otic solution
Regulatory status
No regulatory data for: πΊπΈ US Β· πͺπΊ EU Β· π¬π§ UK Β· ππ° HK Β· πΉπΌ TW Β· π―π΅ JP Β· π°π· KR Β· π¦πΊ AU
Storage & stability
Store milbemycin oxime tablets at room temperature.
Client information
- Compliance is key: Give this medication exactly as prescribed, usually once a month on the same day.
- Watch them eat it: Ensure your pet completely consumes the tablet. If they spit it out, they will not be protected.
- Testing required: Your pet must have a negative heartworm test before starting this medication.
- Side effects: Very rare at standard monthly doses. If your pet is being treated for mange at higher daily doses, watch for and immediately report any stumbling, tremors, excessive drooling, or extreme lethargy.
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerβs current label.
